Tianjin-based SinoMed, founded in 2007, makes interventional medical devices such as coronary stent systems and balloon catheters.
Established in 2007 and based in Tianjin, China, SinoMed manufactures interventional medical devices, including coronary stent systems and balloon dilatation catheters. It has subsidiaries in Beijing, Suzhou, Hong Kong, the United States, Japan and France, and has obtained more than 200 patents. In July 2017 it raised CNY 300 million in strategic investment, and in October 2019 it was listed on the Shanghai Stock Exchange. Stage: Series C.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in